Hospitals, including those participating in the 340B Drug Pricing Program, are the true safety-net, not the pharmaceutical industry with its “skyrocketing prescription drug prices and huge profits,” AHA Executive Vice President Tom Nickels writes in an AHASTAT blog post today. Nickels notes that hospitals care for all patients regardless of their ability to pay, and they have provided more than $500 billion in uncompensated care since 2000. He also highlights that hospitals participating in the 340B program use savings from the program to “provide free or reduced-priced prescription drugs to poorer residents” and “reinvest in programs that enhance patient services and access to care.” Nickels also cites various reports detailing the rapid spike in the costs of prescription drugs, including a Centers for Medicare & Medicaid Services report showing that prescription drug spending increased 12.6% in 2014. For more on the 340B program, visit www.aha.org/protect340B.

Headline
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-…
Blog
Public
In think‑tank reports, like the one released this week by Paragon Health Institute, hospitals are often reduced to abstractions — payment rates, charts,…
Headline
As published April 20, the Department of Justice released an interim final rule in the Federal Register to delay compliance dates for states and local…
Headline
The Washington Post yesterday published a letter to the editor from AHA President and CEO Rick Pollack responding to an April 18 editorial criticizing the 340B…
Headline
The AHA today released its Health Care Plan Accountability Update, covering the latest developments in Medicare Advantage, legislation and…
Headline
UnitedHealth Group announced plans to expand its Rural Payment Acceleration Pilot to reduce Medicare Advantage payment processing times for…